Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 13.345 Q1 | 254 | 29 | 68 | 7430 | 2163 | 67 | 27.67 | 256.21 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.919 Q1 | 70 | 20 | 19 | 4722 | 108 | 19 | 6.67 | 236.10 | |
3 | Reviews in Contemporary Pharmacotherapy | journal | 0.471 Q2 | 18 | 1 | 27 | 209 | 34 | 27 | 0.60 | 209.00 | |
4 | Pharmacology and Therapeutics | journal | 3.119 Q1 | 233 | 62 | 196 | 12447 | 1525 | 193 | 7.67 | 200.76 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 13 | 45 | 1928 | 159 | 44 | 3.52 | 148.31 | |
6 | Progress in Medicinal Chemistry | journal | 0.872 Q1 | 38 | 8 | 25 | 1155 | 61 | 16 | 2.42 | 144.38 | |
7 | Medicinal Research Reviews | journal | 2.603 Q1 | 150 | 29 | 76 | 4077 | 597 | 76 | 8.13 | 140.59 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 0.699 Q2 | 96 | 39 | 43 | 5178 | 82 | 43 | 1.91 | 132.77 | |
9 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.288 Q3 | 45 | 22 | 19 | 2881 | 13 | 17 | 0.68 | 130.95 | |
10 | Annual Review of Pharmacology and Toxicology | journal | 11.847 Q1 | 224 | 25 | 83 | 3063 | 1871 | 82 | 23.20 | 122.52 | |
11 | Current Vascular Pharmacology | journal | 69 | 33 | 0 | 3801 | 0 | 0 | 0.00 | 115.18 | ||
12 | Infectious Disorders - Drug Targets | journal | 0.668 Q2 | 61 | 33 | 57 | 3759 | 119 | 55 | 2.09 | 113.91 | |
13 | Current Drug Targets: Inflammation and Allergy | journal | 0.161 Q3 | 53 | 27 | 26 | 2956 | 7 | 26 | 0.27 | 109.48 | |
14 | Current Medicinal Chemistry | journal | 1.567 Q1 | 202 | 194 | 341 | 21208 | 1642 | 319 | 4.35 | 109.32 | |
15 | Current Drug Metabolism | journal | 1.339 Q1 | 122 | 38 | 87 | 4033 | 382 | 82 | 4.28 | 106.13 | |
16 | Current Cancer Drug Targets | journal | 1.097 Q1 | 103 | 39 | 36 | 3957 | 140 | 36 | 3.89 | 101.46 | |
17 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.906 Q1 | 108 | 41 | 57 | 4139 | 140 | 55 | 2.46 | 100.95 | |
18 | Current Drug Targets | journal | 1.255 Q1 | 119 | 62 | 90 | 6207 | 306 | 83 | 3.09 | 100.11 | |
19 | Expert Opinion on Therapeutic Targets | journal | 0.556 Q2 | 106 | 61 | 145 | 6058 | 209 | 142 | 1.67 | 99.31 | |
20 | Current Pharmaceutical Design | journal | 1.372 Q1 | 183 | 249 | 431 | 24398 | 1995 | 370 | 5.13 | 97.98 | |
21 | Clinical Pharmacokinetics | journal | 1.316 Q1 | 184 | 82 | 236 | 7970 | 1235 | 228 | 4.62 | 97.20 | |
22 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
23 | CNS Drug Reviews | journal | 0.648 Q2 | 64 | 22 | 72 | 1957 | 148 | 72 | 2.65 | 88.95 | |
24 | Drug Resistance Updates | journal | 1.502 Q1 | 132 | 33 | 114 | 2929 | 467 | 106 | 5.09 | 88.76 | |
25 | Cellular and Molecular Life Sciences | journal | 3.001 Q1 | 261 | 236 | 561 | 20896 | 3039 | 545 | 5.26 | 88.54 | |
26 | American Journal of Respiratory Medicine | journal | 0.140 Q4 | 34 | 42 | 51 | 3646 | 14 | 45 | 0.27 | 86.81 | |
27 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
28 | Toxicological Reviews | journal | 49 | 23 | 0 | 1905 | 0 | 0 | 0.00 | 82.83 | ||
29 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 43 | 20 | 0 | 1615 | 0 | 0 | 0.00 | 80.75 | ||
30 | Mini-Reviews in Medicinal Chemistry | journal | 0.550 Q2 | 107 | 74 | 89 | 5792 | 169 | 89 | 1.90 | 78.27 | |
31 | Expert Opinion on Biological Therapy | journal | 0.869 Q1 | 102 | 116 | 176 | 9049 | 509 | 167 | 2.89 | 78.01 | |
32 | Expert Review of Vaccines | journal | 0.190 Q3 | 105 | 78 | 57 | 5374 | 27 | 53 | 0.47 | 68.90 | |
33 | Molecular Diagnosis and Therapy | journal | 68 | 57 | 172 | 3899 | 289 | 159 | 1.82 | 68.40 | ||
34 | Expert Opinion on Pharmacotherapy | journal | 0.541 Q2 | 93 | 204 | 417 | 13857 | 824 | 403 | 1.90 | 67.93 | |
35 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 154 | 3514 | 3 | 154 | 0.02 | 67.58 | |
36 | Drugs of Today | journal | 0.211 Q3 | 57 | 90 | 298 | 6018 | 178 | 296 | 0.75 | 66.87 | |
37 | Drug Safety | journal | 0.981 Q1 | 140 | 82 | 257 | 5422 | 1071 | 252 | 3.67 | 66.12 | |
38 | Annual Report of Shionogi Research Laboratory | journal | 0.105 Q4 | 2 | 1 | 4 | 64 | 0 | 4 | 0.00 | 64.00 | |
39 | Apoptosis : an international journal on programmed cell death | journal | 2.224 Q1 | 128 | 67 | 167 | 4199 | 760 | 165 | 4.73 | 62.67 | |
40 | Receptors and Channels | journal | 0.887 Q1 | 44 | 40 | 71 | 2478 | 131 | 67 | 2.00 | 61.95 | |
41 | Expert Opinion on Therapeutic Patents | journal | 0.453 Q2 | 88 | 125 | 408 | 7681 | 547 | 404 | 1.44 | 61.45 | |
42 | BioDrugs | journal | 0.499 Q2 | 79 | 55 | 198 | 3338 | 362 | 187 | 2.74 | 60.69 | |
43 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.100 Q4 | 5 | 10 | 39 | 590 | 0 | 39 | 0.00 | 59.00 | |
44 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.131 Q4 | 5 | 8 | 27 | 464 | 3 | 27 | 0.13 | 58.00 | |
45 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 0.697 Q2 | 150 | 148 | 392 | 8355 | 778 | 388 | 2.13 | 56.45 | |
46 | Cardiovascular Drug Reviews | journal | 0.478 Q2 | 54 | 24 | 76 | 1324 | 143 | 76 | 2.52 | 55.17 | |
47 | Current Opinion in Investigational Drugs | journal | 0.579 Q2 | 83 | 178 | 271 | 9705 | 545 | 254 | 2.01 | 54.52 | |
48 | Topics in antiviral medicine | journal | 46 | 27 | 0 | 1457 | 0 | 0 | 0.00 | 53.96 | ||
49 | Current Opinion in Drug Discovery and Development | journal | 0.700 Q2 | 85 | 94 | 252 | 4970 | 556 | 238 | 2.34 | 52.87 | |
50 | Neuropsychopharmacology | journal | 2.486 Q1 | 249 | 274 | 538 | 14161 | 3018 | 505 | 5.11 | 51.68 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®